GE HealthCare Technologies Inc.
GEHC
NASDAQ·Healthcare·Medical - Devices·Mkt cap $31.9B
$69.03
▼ -2.17%
P/E
20.01
Mkt Cap
$31.9B
52-Wk Range
$58.75–$89.77
52-Week Range
$58.75 - $89.77
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 2.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Comprehensive medical technology ecosystem
- Global distribution and service network
- Advanced R&D capabilities
- Strong brand reputation in healthcare technology
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Rising global healthcare technology investments
Value
Attractively priced below Healthcare IT & Services peer average
Momentum
Strong
+13.8% over 3m
Quality
Strong
Strong fundamentals
Dividend
Token
0.20% yield
Smart-money signal
Who's buying GEHC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
JUL 29, 2026
Reported EPS of $1.13 vs $1.04 consensus (+8.7% surprise). Revenue of $5.3B vs $5.3B expected (+0.6%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+8.7%
Revenue trend · last 8Q
—
+2%
+3%
+3%
+6%
-12%
+7%
+6%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$4.9B
$5.3B
$4.8B
$5.0B
$5.1B
$4.7B
$5.1B
$5.3B
Margins · last 8Q
Gross
41.2%
Operating
14.0%
Profit
10.6%
Wall Street consensus
13 analysts · 54% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
54%
Hold
46%
Sell
0%
Median Price Target
—
Latest: Citi · Jul 30, 2026
vs Industry
How GEHC stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related